Shenzhen YHLO Biotech Co., Ltd. engages in the research, development, production and sales of in vitro diagnostic instruments and supporting reagents based on chemiluminescence immunoassay solution for diagnosis of autoimmune diseases, reproductive health, and infectious diseases. It focuses on healthcare and better life with technology. The company was founded on September 17, 2008 and is headquartered in Shenzhen, China. .
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company